ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Alterity Therapeutics Ltd

Alterity Therapeutics Ltd (ATH)

0.0095
0.0005
(5.56%)
Closed January 14 11:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.0095
Bid
0.009
Ask
0.01
Volume
2,708,770
0.009 Day's Range 0.0095
0.002 52 Week Range 0.012
Market Cap
Previous Close
0.009
Open
0.009
Last Trade
481
@
0.009
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
14,583,966
Shares Outstanding
2,416,418,418
Dividend Yield
-
PE Ratio
-1.27
Earnings Per Share (EPS)
-0.01
Revenue
4.02M
Net Profit
-19.12M

About Alterity Therapeutics Ltd

Sector
Biological Pds,ex Diagnstics
Industry
Health Care Diversified
Headquarters
Melbourne, Victoria, Aus
Founded
1997
Alterity Therapeutics Ltd is listed in the Biological Pds,ex Diagnstics sector of the Australian Stock Exchange with ticker ATH. The last closing price for Alterity Therapeutics was AUD0.01. Over the last year, Alterity Therapeutics shares have traded in a share price range of AUD 0.002 to AUD 0.012.

Alterity Therapeutics currently has 2,416,418,418 shares outstanding. The market capitalization of Alterity Therapeutics is AUD21.75 million. Alterity Therapeutics has a price to earnings ratio (PE ratio) of -1.27.

ATH Latest News

ADRs End Higher, Shell and Eisai Trade Actively

By Kathryn Hardison International stocks trading in New York closed higher on Friday. The S&P/BNY Mellon index of American depositary receipts increased 2.2% to 148.13. The European index...

Alterity Therapeutics Shares Reverse Course, Hit 52-Week Low

By Chris Wack Alterity Therapeutics Ltd. shares reversed course Tuesday, dropping 13% to 49 cents, after the company said it received approval for its investigational new drug application by the...

Alterity Therapeutics Gets FDA Approval for IND Application for ATH434

By Chris Wack Alterity Therapeutics Ltd. said it has received approval from the U.S. Food and Drug Administration for its Investigational New Drug application to allow evaluation of ATH434 in...

Alterity Therapeutics Announces Successful Completion of Phase 1 Clinical Trial

Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”) today announced that it has successfully completed its Phase 1 study of PBT434, a novel, orally bioavailable...

Initial Data for Alterity Therapeutics Phase 1 Clinical Trial Released at American Academy of Neurology Annual Meeting

Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”) is today releasing interim clinical data of its Phase 1 clinical trial program for its investigative drug...

Alterity Therapeutics Presents at the American Academy of Neurology Annual Meeting

Alterity Therapeutics Limited, (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”) will present clinical data from its lead drug candidate PBT434 at the American Academy of Neurology...

Anthem Introduces Health and Wellness Web Site for Baby Boomers and Seniors

Anthem Introduces Health and Wellness Web Site for Baby Boomers and Seniors INDIANAPOLIS, Oct. 5 /PRNewswire/ -- Baby boomers and seniors can now access online information and tools tailored...

Anthem Annual Report Wins Gold in International Competition

Anthem Annual Report Wins Gold in International Competition INDIANAPOLIS, Sept. 21 /PRNewswire/ -- Anthem Inc.'s 2003 summary annual report has won a gold award at the 18th Annual International...

Second Diversity Leadership Academy Class Named

Second Diversity Leadership Academy Class Named INDIANAPOLIS, Aug. 26 /PRNewswire/ -- A diverse group of 58 community leaders have been selected to participate in this year's Diversity...

Anthem Recognized As One of the Top 100 Agile Companies By CIO Magazine

Anthem Recognized As One of the Top 100 Agile Companies By CIO Magazine INDIANAPOLIS, Aug. 19 /PRNewswire/ -- Anthem, Inc. has been recognized by CIO magazine as a recipient of the "2004 CIO 100...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0005-50.010.0120.009251374340.00977201DE
40.003558.33333333330.0060.0120.0055242322160.00834261DE
120.0065216.6666666670.0030.0120.002145839660.00646256DE
260.003558.33333333330.0060.0120.002137120750.00539588DE
520.0055137.50.0040.0120.002111725060.00521483DE
156-0.0115-54.76190476190.0210.0220.00260903530.00693761DE
260-0.0105-52.50.020.410.00275863340.02602328DE

ATH - Frequently Asked Questions (FAQ)

What is the current Alterity Therapeutics share price?
The current share price of Alterity Therapeutics is AUD 0.0095
How many Alterity Therapeutics shares are in issue?
Alterity Therapeutics has 2,416,418,418 shares in issue
What is the market cap of Alterity Therapeutics?
The market capitalisation of Alterity Therapeutics is AUD 21.75M
What is the 1 year trading range for Alterity Therapeutics share price?
Alterity Therapeutics has traded in the range of AUD 0.002 to AUD 0.012 during the past year
What is the PE ratio of Alterity Therapeutics?
The price to earnings ratio of Alterity Therapeutics is -1.27
What is the cash to sales ratio of Alterity Therapeutics?
The cash to sales ratio of Alterity Therapeutics is 5.88
What is the reporting currency for Alterity Therapeutics?
Alterity Therapeutics reports financial results in AUD
What is the latest annual turnover for Alterity Therapeutics?
The latest annual turnover of Alterity Therapeutics is AUD 4.02M
What is the latest annual profit for Alterity Therapeutics?
The latest annual profit of Alterity Therapeutics is AUD -19.12M
What is the registered address of Alterity Therapeutics?
The registered address for Alterity Therapeutics is LEVEL 3, 62 LYGON STREET, CARLTON, MELBOURNE, VICTORIA, 3053
What is the Alterity Therapeutics website address?
The website address for Alterity Therapeutics is www.alteritytherapeutics.com
Which industry sector does Alterity Therapeutics operate in?
Alterity Therapeutics operates in the HEALTH CARE DIVERSIFIED sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WLDWellard Limited
AUD 0.15
(105.48%)
6.79M
EXTODExcite Technology Services Ltd
AUD 0.002
(100.00%)
1.14M
LNRLanthanein Resources Ltd
AUD 0.003
(50.00%)
600k
APCOAPC Minerals Ltd
AUD 0.003
(50.00%)
405.97k
HWKOHawk Resources Ltd
AUD 0.01
(42.86%)
1
NHEOANoble Helium Ltd
AUD 0.004
(-69.23%)
769.23k
MMROMEC Resources Ltd
AUD 0.001
(-50.00%)
4.88M
RADORadiopharm Theranostics Ltd
AUD 0.004
(-42.86%)
922.36k
KNGOKingsland Minerals Ltd
AUD 0.015
(-34.78%)
37.5k
CRIOCritica Ltd
AUD 0.002
(-33.33%)
1.67M
MTLMantle Minerals Limited
AUD 0.001
(0.00%)
245.05M
MRQOMRG Metals Limited
AUD 0.001
(0.00%)
104.12M
SGRStar Entertainment Group Limited
AUD 0.14
(12.00%)
53.77M
OB1Orbminco Ltd
AUD 0.002
(0.00%)
34.7M
TMGTrigg Minerals Ltd
AUD 0.048
(-2.04%)
33.55M

Discussion

View Full Feed
Hi_Lo Hi_Lo 5 minutes ago
Where is the CSE press release filing?

TWOH has been halted for more than a week now and the CSE press release is still missing.

Could the run up before the halt be the problem?

Could some people have been tipped off before the run up?

Coul
TWOH
SkeBallLarry SkeBallLarry 12 minutes ago
https://scontent-mia3-1.xx.fbcdn.net/v/t39.30808-6/473323273_992397186268896_4170433101098362110_n.jpg?_nc_cat=100&ccb=1-7&_nc_sid=833d8c&_nc_ohc=UebR9WKXEXsQ7kNvgELlMGV&_nc_zt=23&_nc_ht=scontent-mia3-1.xx&_nc_gid=AvB9U-Cb1bfWGguzkXzMzar&oh=00_AYDqG-tA0ScuUz90hSjz11X1LQL5aezyuhOfdBXmp9pGuQ&oe=678C04
Dodger1 Dodger1 14 minutes ago
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175652942 I Miss Real
AABB
jondoeuk jondoeuk 17 minutes ago
NEUK201-00* is being tested in advanced/metastatic solid tumours at a single site.

https://i.postimg.cc/fyWcxcwj/download.png

* It could be an iNK with just a high-affinity non-cleavable CD16(a) receptor, but this comes from a Chinese site that has under
HPQ
marcis marcis 18 minutes ago
I was just thinking the same thing

Go bother those serial OTC stock hijackers
( we know them all well ) that’s been doing LOI mergers, asset ( no asset ) transfers for years with never a real company.
( not you Prophet, to the shills )
Save those investors
RDAR
No-Quarter No-Quarter 19 minutes ago
Good to know, thx!
LetGoodTimesRoll LetGoodTimesRoll 19 minutes ago
The criminality surrounding BLUE Sheets data is rampant...

https://www.sec.gov/newsroom/press-releases/2025-5?utm_medium=email&utm_source=govdelivery
FOXO
Seminole Red Seminole Red 20 minutes ago
https://scontent-mia3-2.xx.fbcdn.net/v/t39.30808-6/472742874_1004087688423643_1614366062036311373_n.jpg?_nc_cat=1&ccb=1-7&_nc_sid=833d8c&_nc_ohc=nfcGrMsEIhAQ7kNvgF3nw1U&_nc_zt=23&_nc_ht=scontent-mia3-2.xx&_nc_gid=AZgGdnGS_3zIT8EnJ2PY5KX&oh=00_AYA_PYWQyRmy2OxdvryhKxL8uHQSf69FZtEDZ_CZJ06VFQ&oe=678BF3D
Bubae Bubae 20 minutes ago
New shares flying everywhere from the looks of the filings. Form 144 filed on January 10th by Atlas Merchant Capital LLC intent to sell 1,241,144 shares. approximate date of sale listed as 01/10/2025. Robert E. Diamond, Triller Chairman of the Board, Chief Executive Officer of Atlas Merchant Capita
ILLR
meshcan meshcan 22 minutes ago
Yes, hence I was saying the really numbers will be in a couple quarters from now, August CC will be two full quarters that we have Vyvanse sell numbers.

CC: NASDAC2020
ELTP
PlaneReflection PlaneReflection 22 minutes ago
Remember when you said it won't pass $2 again?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174119656

Please say it won't pass $10 again, $30 again and it'll never be over $200. Thanks.
FNMA
eagle8 eagle8 24 minutes ago
ATLnsider
@ATLnsider
Global future for $NWBO #DCVax dendritic cell vaccine platform could be unlimited if efficacy is proven to be tumor & tissue agnostic for all solid tumor cancers & when combined with checkpoint inhibitors can also effectively treat all blood or liquid cancers. NWBi
NWBO
PROPHET-of-PROFITS PROPHET-of-PROFITS 24 minutes ago
The old CEO of rdar has a new stock already to transfer all of his garbage into. But you watch the bearish comments here Will Never follow Jacob to that new stock where efforts should be made to protect people from making a bad investment. Negative bearish comments and all the effort to create them
RDAR
Pickme2 Pickme2 25 minutes ago
The only proof here is you constantly saying this is the best setup and challenge...yet it keeps going down down from .31 cents to .03 ...now .05  and despite the company saying this S-1 offering filled with the SEC will cause dilution and shareholders will have a hard time selling...you continue to
ATMH
PC retired PC retired 27 minutes ago
Yes, it has gone deathly quiet. I have little to say other than wishing you, Richard H2, a happy and prosperous new year.
ASRE
eagle8 eagle8 28 minutes ago
Someone without a name wrote this ;)

➡️MTD Timeline: More Speculation⬅️

For all of those, including myself, (im)patiently waiting for $NWBO's spoofing case Motion to Dismiss (MTD) decision, I've done a deep dive into Magistrate Judge Stein's Report and Recommendation (R
NWBO
marcis marcis 31 minutes ago
Agree
The deep experience management team is on this
And with $45 million working capital

Buckle up
RDAR
marcis marcis 35 minutes ago
It’s my opinion that, JanBelle Capital or an associate fund, was the short buyer of $100k one big size trade at the high of the day .002 Dec 06

I think that the short position, if I’m correct, is about finished after making a cool $80,00” - $90,000 minus fees for the month
RDAR
edbi46 edbi46 36 minutes ago
No WORD SALADS, no SUBSTANTIAL/NONE SUBSTANTIAL ACCUSATIONS, ( for like 10 years since Oct. 2015 and counting?? ), did/will do any desired effect !!!!! We know they are watching BASHING work here, before the checks are being cut!!!

-----------------------------------------------------
BMI MCF QUBT
Good Sport Good Sport 40 minutes ago
This article I kept (below) was from many years ago but states we had partnered with Pfizer...


Health Discovery Corp Hires the Dilenschneider Group
Health Discovery Corporation hires The Dilenschneider Group, a New York City IR/PR firm

SAVANNAH, Ga.- Heal
ABT DGX HDVY
Good Sport Good Sport 40 minutes ago
This post needs deleted please. Duplicate
ABT DGX HDVY

Your Recent History

Delayed Upgrade Clock